BackSpringWorks Therapeutics Overview

SpringWorks Therapeutics Research & Development

Research & Development expenses for SWTX.

Quarterly R&D Expenses

$49.59M
↓ 7.51% YoY

As of Mar 31, 2025

Annual R&D Expenses (TTM)

$196.49M
↑ 15.19% YoY

Trailing 12 months ending Mar 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin